Show simple item record

dc.contributor.authorAgbaje, AO
dc.contributor.authorBarker, AR
dc.contributor.authorMitchell, GF
dc.contributor.authorTuomainen, T-P
dc.date.accessioned2022-03-24T12:13:57Z
dc.date.issued2022-01-18
dc.date.updated2022-03-24T10:57:47Z
dc.description.abstractBACKGROUND: We investigated the temporal causal longitudinal associations of carotid-femoral pulse wave velocity (cfPWV), a measure of arterial stiffness, and carotid intima-media thickness (cIMT) progression with the risk of dysglycemia, insulin resistance, and dyslipidemia. METHODS: We included 3862, 17.7-year-old, participants from the Avon Longitudinal Study of Parents and Children, followed up for 7 years. cfPWV, cIMT, and fasting plasma samples were repeatedly measured. We computed homeostatic model assessment (HOMA) of insulin resistance and percent pancreatic beta-cell function. Data were analyzed using logistic regression, linear mixed-effect, and cross-lagged structural equation models. RESULTS: A higher cfPWV at 17.7 years was associated with higher insulin at age 24.5 years (odds ratio, 1.25 [CI, 1.08-1.44]; P=0.003), which slightly attenuated after covariates adjustment. Higher cIMT at 17.7 years was associated with lower insulin (odds ratio, 0.06 [0.01-0.95]; P=0.046) at 24.5 years, after covariate adjustments. In mixed-effect models, the 7-year progression in cfPWV (predictor) was directly associated with the increase in triglyceride (outcome). cIMT progression was associated with the 7-year increase in LDL (low-density lipoprotein), triglyceride, and glucose. In cross-lagged models, higher cfPWV at 17.7 years was associated with higher insulin (β=0.06, SE, 0.12, P=0.014), HOMA of insulin resistance, and HOMA-percent pancreatic beta-cell function at 24.5 years. However, insulin, HOMA of insulin resistance, and HOMA-percent pancreatic beta-cell function at 17.7 years were not associated with cfPWV at 24.5 years. Higher cIMT at 17.7 years was associated with reduced insulin, HOMA of insulin resistance, and HOMA-percent pancreatic beta-cell function at 24.5 years, but not vice versa. Higher glucose at 17.7 years was associated with higher cfPWV and cIMT at 24.5 years only. CONCLUSIONS: Arterial stiffness in adolescence may be a causal risk factor for hyperinsulinemia and insulin resistance in young adulthood.en_GB
dc.format.extent667-678
dc.identifier.citationVol. 79(3), pp. 667-678en_GB
dc.identifier.doihttps://doi.org/10.1161/HYPERTENSIONAHA.121.18754
dc.identifier.urihttp://hdl.handle.net/10871/129148
dc.identifierORCID: 0000-0001-8610-5417 (Barker, Alan R)
dc.identifierScopusID: 14008425100 (Barker, Alan R)
dc.identifierResearcherID: AAF-7777-2020 (Barker, Alan R)
dc.language.isoenen_GB
dc.publisherAmerican Heart Association / Lippincott, Williams & Wilkinsen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35038890en_GB
dc.relation.urlhttp://www.bristol.ac.uk/alspac/researchers/our-data/en_GB
dc.rights© 2022 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.en_GB
dc.subjectadolescenten_GB
dc.subjectatherosclerosisen_GB
dc.subjectcausalityen_GB
dc.subjectdiabetes mellitus, type 2en_GB
dc.subjecthyperglycemiaen_GB
dc.subjectmetabolic syndromeen_GB
dc.subjectyoung adulten_GB
dc.titleEffect of Arterial Stiffness and Carotid Intima-Media Thickness Progression on the Risk of Dysglycemia, Insulin Resistance, and Dyslipidemia: a Temporal Causal Longitudinal Studyen_GB
dc.typeArticleen_GB
dc.date.available2022-03-24T12:13:57Z
dc.identifier.issn0194-911X
exeter.place-of-publicationUnited States
dc.descriptionThis is the final version. Available on open access from the American Heart Association via the DOI in this recorden_GB
dc.descriptionData Availability Statement: The informed consent obtained from ALSPAC participants does not allow the data to be made freely available through any third-party maintained public repository. However, data used for this submission can be made available on request to the ALSPAC Executive. The ALSPAC data management plan describes in detail the policy regarding data sharing, which is through a system of managed open access. Full instructions for applying for data access can be found here: http://www.bristol.ac.uk/alspac/researchers/access/. The ALSPAC study website contains details of all the data that are available (http://www.bristol.ac.uk/alspac/researchers/our-data/).en_GB
dc.identifier.eissn1524-4563
dc.identifier.journalHypertensionen_GB
dc.relation.ispartofHypertension, 79(3)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_GB
dcterms.dateAccepted2022-01-03
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-01-18
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-03-24T12:09:07Z
refterms.versionFCDVoR
refterms.dateFOA2022-03-24T12:14:07Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2022 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
Except where otherwise noted, this item's licence is described as © 2022 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.